With regard to the voting, I fully think we need to do whatever is possible to stay on NASDAQ. With that being said, I think there are ways to create a trap by voting yes on everything. Superficially it looks like we are voting on dilution with more shares and a reverse split. With an announcement of a reverse split, but then a granting of shares to people that own shares and still own them from a prior date, it would squeeze the naked shorts to death. At the same time rewarding long-term investor loyalty and reducing the potential reverse split affect on them. The granted shares could even be in the form of restricted shares or in warrants with no sale dates applied. Possible dividends associated with the long-term holding of new shares? There are lots of options to reduce the risk for long-term investors and screw these naked shorts.
The best method, of course, is to start earning via the platform. Rory has an interest in focusing on the entertainment value of livestream shopping but perhaps they should open a 2nd avenue on the site for garage sale livestreaming to the masses. My fear is the entertainment value might take too long to develop. The valuation of other companies livestreaming is certainly much higher than verb. We are currently sitting at barely more than gross earnings with our market cap. That is ridiculous. I’m certainly glad to see the strong updates in the SAA division of verb. I hope quarterly growth of sales shows this with a nice bump this quarter
(10)
(0)
Verb Technology Company, Inc (VERB) Stock Research Links
Overview of Tilray Brands, Inc.
Tilray Brands, Inc. (NASDAQ: TLRY) is a pioneering company in the field of medical and recreational cannabis production and research. Headquartered in Canada, Tilray has positioned itself as a global leader with a commitment to providing safe, consistent, and reliable therapy to patients and consumers worldwide. The company operates in multiple regions, including Canada, the United States, Europe, Australia, and Latin America, serving a diverse clientele rangin... Continue Reading
Introduction to Demand Generation
In the fast-paced world of digital marketing and advertising, understanding the demand generation process is crucial for business growth. Demand generation is a comprehensive strategy aimed at creating awareness and interest in a company's products or services, ultimately driving customer engagement and revenue. For advertisers, especially in the realm of connected TV advertising, mastering demand generation can significantly enhance performance marketing... Continue Reading
Philips Reports Strong Order Intake Growth in Q2 2024
With a 9% rise over past periods, Philips's order intake in Q2 2024 rose significantly. Mostly, the North American market drove this expansion. With group sales of EUR 4.5 billion, the company said that comparable sales had risen by 2%. Operations brought in EUR 816 million, of which EUR 538 million came from insurance earnings. The changed EBITA margin climbed to 11.1% of sales. Apart from a free cash outflow of EUR 64 million, Philip... Continue Reading
Burcon NutraScience Achieves Milestone in Canola Protein Production
Leader in plant-based protein technologies, Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) has effectively finished its first end-to-end validation trial for manufacturing high-purity canola protein isolate. For Burcon's goal of releasing creative, plant-based protein solutions onto the market, this success represents a major forward step.
Commercialization of Canola Protein Technology
Burcon's commerc... Continue Reading
Category: StocksTotal Views: 150 By : Caleb PriceUpdated: 07-29-2024
Acquisition of Mineral Claims in Athabasca Basin
Skyharbour Resources LTD. has signed an asset purchase agreement with Cosa Resources Corp. Signed July 26, 2024, the agreement calls for acquiring two mineral claims in the Athabasca Basin, Saskatchewan. With 12,718 hectares, these claims will double the footprint of the Orbit uranium project. With this purchase, Cosa will be able to increase its eight kilometer control of untested strike length. The claims follow trend with uranium mineralizat... Continue Reading
Category: StocksTotal Views: 176 By : Riley HayesUpdated: 07-29-2024
reAlpha Acquires 85% Stake in Hyperfast Title, LLC
85% of Hyperfast Title, LLC. has been acquired by reAlpha Tech Corp. Hyperfast calls Florida, Virginia, and Tennessee home. This purchase expands the portfolio of reAlpha with title and settlement services. Re Alpha is renowned for creating real estate artificial intelligence technologies. The purchase from Madison Settlement Services fits the expansion plan of reAlpha. This action enhances the homebuying market offerings from reAlpha. The in... Continue Reading
The Rise of Generative AI: Transforming Industries and Investment Strategies
By allowing the creation of fresh content—text and images as well as music and design—generative artificial intelligence is changing sectors. Companies use this technology to improve operations and boost inventiveness. Generative artificial intelligence creates tailored marketing materials in advertising, so boosting interaction. In the medical field, it helps with new medical imaging creation and drug di... Continue Reading
Anavex Life Sciences Reports Promising Results for Alzheimer's Treatment
From its Phase IIb/III study on blarcamesine (ANAVEX®2-73), a medication for early Alzheimer's disease (AD), Anavex Life Sciences Corp. (Nasdaq: AVXL) has reported encouraging findings. Leading neurology specialist Dr. Marwan Noel Sabbagh delivered the data at the 2024 Alzheimer's Association International Conference (AAIC). Taken once daily, blarcamesine has shown great promise in halting the advance of ... Continue Reading
Category: StocksTotal Views: 273 By : Lucas YoungUpdated: 07-28-2024
Windtree Therapeutics Updates Istaroxime Clinical Development and Trial Data
Providing a thorough update on the clinical and business development of istaroxime, Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company committed to developing creative therapies for critical diseases, has This first-in-class treatment seeks to raise blood pressure, preserve or increase renal function, and strengthen systolic contraction and diastolic relaxation of the heart. In three Phase 2 trials... Continue Reading
SEC Charges Andrew Left and Citron Capital in $20 Million Fraud Scheme
Andrew Left and his company, Citron Capital LLC, have been charged with a $20 million fraud by the Securities and Exchange Commission (SEC). They are activists short sellers. The SEC complaint claims Left recommended stock positions using his Citron Research website and social media platform. He said these positions complemented Citron Capital's and his own investments. Left's recommendations, according to the SEC,... Continue Reading